Aptar Pharma to highlight trends in drug delivery at CPhI India

Published: 17-Nov-2017

Aptar Pharma, a drug delivery systems provider, is pleased to be an exhibitor once again at CPhI India 2017, which takes place at the Bombay Exhibition Centre (BEC), Mumbai, India from 28–30 November

For the past few years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry in Asia.

This year, the Aptar Pharma booth, located at stand no H77, Hall 1, will showcase Aptar Pharma’s wide product portfolio covering various routes of administration, including connected device systems for better patient adherence and compliance.

A dedicated innovation area will feature the megatrends that are currently influencing the drug delivery industry.

Driving Better Patient Adherence with Connectivity

Aptar Pharma will also present a pharma talk focused on connected healthcare solutions, one such growing megatrend.

Presented by Sai Shankar, Director Business Development — Connected Devices, Aptar Pharma’s Exhibitor Showcase will reveal the findings of a recent study on its integrated connected pMDI.

He will also present the company’s connected health devices portfolio that supports respiratory treatment for patients.

Using a patient-centric design approach, Aptar Pharma supports Pharma companies worldwide with custom-made solutions, including connected technologies, for the treatment of respiratory diseases including asthma and COPD.

Sai Shankar’s Exhibitor Showcase will take place on Tuesday, 28 November 13:00–13.45 at Hall 7A, Goregaon.

Join Aptar Pharma at booth No. 77, Hall 1, where its team of experts will be pleased to provide an overview of its wide product portfolio that offers innovative drug delivery systems, components and services covering a broad range of delivery routes.

You may also like